MTC vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

MTC

26.6
AI Score
VS
HIVE Wins

HIVE

48.3
AI Score

Investment Advisor Scores

MTC

27score
Recommendation
SELL

HIVE

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MTC HIVE Winner
Revenue 807,500 297.79M HIVE
Net Income -56.08M -148.45M MTC
Gross Margin 21.6% -21.0% MTC
Net Margin -6944.3% -49.8% HIVE
ROE -386.2% -28.0% HIVE
ROA -304.5% -23.2% HIVE
Total Assets 18.42M 639.15M HIVE
Cash 8.19M 23.11M HIVE
Current Ratio 12.50 1.10 MTC

Relative Price Performance (Last 90 Days)

MTC 1M: +56.4% · 3M: +61.8% HIVE 1M: +10.6% · 3M: -20.1%

Current Technical Phase

MTC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.6% over 20 days), RSI 71

RSI (14): 71.1 · Price: $4.74

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.8 · Price: $3.03

Fundamentals Snapshot

Metric MTC HIVE
Market Cap
Forward P/E 0.0 -5.9
Trailing P/E 6.4
Revenue (TTM)
Revenue Growth -1.0% 0.7%
Gross Margin 0.4%
Operating Margin 0.0% -0.6%
EPS 0.74 -1.33
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.